{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:56:14Z","timestamp":1762876574151,"version":"3.45.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"United States National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000135"],"award-info":[{"award-number":["UL1TR000135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.livres.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T08:30:41Z","timestamp":1558945841000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist"],"prefix":"10.1016","volume":"3","author":[{"given":"Adnan","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani A.","family":"Kardashian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kais","family":"Zakharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-6811","authenticated-orcid":false,"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-1702","authenticated-orcid":false,"given":"James H.","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2019.04.001_bib1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2019.04.001_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.25977","article-title":"Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4","volume":"58","author":"Ellinghaus","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.livres.2019.04.001_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gie.2010.08.050","article-title":"Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience","volume":"73","author":"Mohamadnejad","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.livres.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199301143280204","article-title":"Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis","volume":"328","author":"Pol","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.179.4.2651","article-title":"Induction of primary biliary cirrhosis in Guinea pigs following chemical xenobiotic immunization","volume":"179","author":"Leung","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.livres.2019.04.001_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-916319","article-title":"Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology","volume":"25","author":"Selmi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib14","doi-asserted-by":"crossref","first-page":"610504","DOI":"10.1155\/2012\/610504","article-title":"Sex differences associated with primary biliary cirrhosis","volume":"2012","author":"Smyk","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.livres.2019.04.001_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestasis liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.21759","article-title":"Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States","volume":"46","author":"Peters","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.livres.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.510290450","article-title":"The pruritus of cholestasis","volume":"29","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.25748","article-title":"Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions","volume":"56","author":"Kremer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years","volume":"20","author":"Mahl","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.20276","article-title":"Quality of life in patients with primary biliary cirrhosis","volume":"40","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2007.01.036","article-title":"Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis","volume":"46","author":"van Os","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.1840400434","article-title":"Primary biliary cirrhosis: report of a focus group","volume":"40","author":"Bergasa","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(19)31870-0","article-title":"Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus","volume":"73","author":"Ghent","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib29","first-page":"152","article-title":"Long-term outcome after partial external biliary diversion for intractable pruritus in patients with intrahepatic cholestasis","volume":"30","author":"Ng","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.livres.2019.04.001_bib30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","article-title":"Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation","volume":"60","author":"Portmann","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.livres.2019.04.001_bib33","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib34","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib35","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.14.3948","article-title":"IgG4-related sclerosing disease","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.livres.2019.04.001_bib38","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.3748\/wjg.v21.i25.7683","article-title":"Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis","volume":"21","author":"Reshetnyak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2019.04.001_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib41","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2019.04.001_bib42","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A\u00a0retrospective single-center review of primary sclerosing cholangitis in children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib45","first-page":"136","article-title":"Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children","volume":"31","author":"Gilger","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.livres.2019.04.001_bib46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2015.02.037","article-title":"Targeting the FXR nuclear receptor to treat liver disease","volume":"148","author":"Neuschwander-Tetri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib48","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2019.04.001_bib49","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2036.2011.04926.x","article-title":"The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study","volume":"35","author":"Martin","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1572-0241.2003.07173.x","article-title":"Methotrexate therapy for primary biliary cirrhosis","volume":"98","author":"Bach","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A\u00a0double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.mcg.0000177230.13770.4e","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid","volume":"39","author":"Talwalkar","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib56","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","article-title":"Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study","volume":"44","author":"Angulo","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib57","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A\u00a0pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1013240225965","article-title":"Pirfenidone in the treatment of primary sclerosing cholangitis","volume":"47","author":"Angulo","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib59","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2019.04.001_bib61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.livres.2019.04.001_bib62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5604\/01.3001.0010.5273","article-title":"Curcumin in hepatobiliary disease: pharmacotherapeutic properties and emerging potential clinical applications","volume":"16","author":"Hu","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib63","first-page":"293","article-title":"Primary sclerosing cholangitis, Part 1: epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep4.1013","article-title":"Update on pharmacotherapies for cholestatic liver disease","volume":"1","author":"Ali","year":"2016","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2019.04.001_bib65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/17474124.2018.1483719","article-title":"Endoscopic management of primary sclerosing cholangitis","volume":"12","author":"Tabibian","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib66","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1600-6143.2011.03969.x","article-title":"Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis","volume":"12","author":"Goldberg","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.livres.2019.04.001_bib67","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib68","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgu\u00e9","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.livres.2019.04.001_bib70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary bilary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib72","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000444544","article-title":"Novel aspects in the management of cholestatic liver diseases","volume":"34","author":"Chazouill\u00e8res","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/14656566.2015.998650","article-title":"Advances in pharmacotherapy for primary biliary cirrhosis","volume":"16","author":"Mousa","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.livres.2019.04.001_bib74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000440761","article-title":"Therapy of primary biliary cirrhosis: novel approaches for patients with suboptimal response to ursodeoxycholic acid","volume":"33","author":"Par\u00e9s","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/17512433.2015.1092381","article-title":"Obeticholic acid for the treatment of primary biliary cirrhosis","volume":"9","author":"Trivedi","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.livres.2019.04.001_bib76","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MEG.0000000000000591","article-title":"Therapeutic advances for primary biliary cholangitis: the old and the new","volume":"28","author":"Wang","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib77","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0Placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib79","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A\u00a0randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib80","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib82","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A\u00a0randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib83","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficiency of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib84","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib85","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib86","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective clinical trial of Rifaximin therapy for patients with primary sclerosing cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","article-title":"Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence","volume":"44","author":"Newton","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib90","doi-asserted-by":"crossref","first-page":"389537","DOI":"10.1155\/2013\/389537","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis","volume":"2013","author":"Tabibian","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.livres.2019.04.001_bib91","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib92","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective clinical trial of Rifaximin therapy for patients with primary sclerosing cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib94","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM196109072651004","article-title":"The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine","volume":"265","author":"Van itallie","year":"1961","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib95","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib96","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM199712113372401","article-title":"Alcohol consumption and mortality among middle-aged and elderly U.S. adults","volume":"337","author":"Thun","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib97","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib98","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ajcn\/23.4.467","article-title":"Effects of ethanol on the liver","volume":"23","author":"Scheig","year":"1970","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.livres.2019.04.001_bib99","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1089-3261(05)70086-6","article-title":"Cholestasis and alcoholic liver disease","volume":"3","author":"Tung","year":"1999","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib101","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cld.197","article-title":"Alcohol consumption as a cofactor for other liver diseases","volume":"2","author":"Altamirano","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib102","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01347921","article-title":"Fulminant hepatitis A in chronic HBV carrier","volume":"31","author":"Wang","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib103","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01312556","article-title":"Acute type A hepatitis in three patients with chronic HBV infection","volume":"28","author":"Conteas","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib104","first-page":"201","article-title":"Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?","volume":"90","author":"Keeffe","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib105","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-110-10-838","article-title":"Fulminant hepatitis A in intravenous drug users with chronic liver disease","volume":"110","author":"Akriviadis","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2019.04.001_bib106","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1995.03530150066036","article-title":"The public's health unprotected. Reversing a decade of underutilization of hepatitis B vaccine","volume":"274","author":"Francis","year":"1995","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.livres.2019.04.001_bib107","first-page":"217","article-title":"Hepatitis: a vaccine","volume":"91","author":"Bader","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib108","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00007","article-title":"Adult immunizations","volume":"124","author":"Gardner","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2019.04.001_bib109","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510270336","article-title":"Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease","volume":"27","author":"Keeffe","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib110","first-page":"1","article-title":"Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.livres.2019.04.001_bib111","first-page":"24","article-title":"Prevention of pneumococcal disease","volume":"4","author":"Deegan","year":"1996","journal-title":"World Ir Nurs"},{"key":"10.1016\/j.livres.2019.04.001_bib112","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0889-8553(21)00240-5","article-title":"Prevention and treatment of drug-induced liver disease","volume":"24","author":"Speeg","year":"1995","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.livres.2019.04.001_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00003495-199300461-00063","article-title":"Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence","volume":"46","author":"Carson","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.livres.2019.04.001_bib114","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0889-8553(21)00235-1","article-title":"Hepatotoxicity of drugs used in the treatment of gastrointestinal disorders","volume":"24","author":"Bashir","year":"1995","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.livres.2019.04.001_bib115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0168-8278(05)80530-6","article-title":"Iron increases ethanol toxicity in rat liver","volume":"17","author":"St\u00e5l","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/0016-5085(92)90339-Z","article-title":"Measurement of iron status in patients with chronic hepatitis","volume":"102","author":"Di Bisceglie","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib117","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib118","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","author":"Longo","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.livres.2019.04.001_bib119","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0016-5085(85)90642-0","article-title":"Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification","volume":"89","author":"Jahn","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","article-title":"Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?","volume":"15","author":"Crippin","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib121","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1136\/gut.2005.079814","article-title":"Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis","volume":"55","author":"Allocca","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.livres.2019.04.001_bib122","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1572-0241.2005.40814.x","article-title":"Chronic liver disease and consumption of raw oysters: a potentially lethal combination--a review of Vibrio vulnificus septicemia","volume":"100","author":"Haq","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib123","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1021\/jf0710985","article-title":"In\u00a0vitro antioxidant activity of coffee compounds and their metabolites","volume":"55","author":"G\u00f3mez-Ruiz","year":"2007","journal-title":"J\u00a0Agric Food Chem"},{"key":"10.1016\/j.livres.2019.04.001_bib124","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1001\/archinternmed.2009.439","article-title":"Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis","volume":"169","author":"Huxley","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.livres.2019.04.001_bib125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijcard.2008.06.051","article-title":"Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies","volume":"137","author":"Wu","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.livres.2019.04.001_bib126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.livres.2019.04.001_bib127","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/liv.12304","article-title":"Impact of coffee on liver diseases: a systematic review","volume":"34","author":"Saab","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2019.04.001_bib128","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.cgh.2013.12.036","article-title":"Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis","volume":"12","author":"Lammert","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib130","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.livres.2019.04.001_bib131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.1840080107","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors","volume":"8","author":"Tit\u00f3","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib133","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fern\u00e1ndez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib134","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0016-5085(91)90219-B","article-title":"Selective intestinal decontamination prevents spontaneous bacterial peritonitis","volume":"100","author":"Soriano","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib135","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial","volume":"12","author":"Gin\u00e9s","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib136","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0016-5085(92)91514-5","article-title":"Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage","volume":"103","author":"Soriano","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib137","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1440-1746.2010.06318.x","article-title":"Minimal hepatic encephalopathy: consensus statement of a working party of the Indian national association for study of the liver","volume":"25","author":"Dhiman","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib138","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1478-3231.2009.02067.x","article-title":"Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis","volume":"29","author":"Sharma","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2019.04.001_bib139","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2036.2011.04808.x","article-title":"Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study","volume":"34","author":"Sanyal","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2019.04.001_bib140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"American association for the study of liver diseases. Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib141","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.livres.2019.04.001_bib142","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","article-title":"Update on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"6","author":"Tsaitas","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib143","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib144","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib145","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib146","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2019.04.001_bib147","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib148","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib149","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib150","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib152","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib153","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib154","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","article-title":"Update on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"6","author":"Tsaitas","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib156","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib157","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib158","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bj\u00f6rnsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib159","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","article-title":"Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment","volume":"71","author":"Gotthardt","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.livres.2019.04.001_bib160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: the role of endoscopic therapy","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib161","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11894-006-0011-y","article-title":"Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation","volume":"8","author":"Johnson","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.livres.2019.04.001_bib162","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.livres.2019.04.001_bib163","first-page":"661","article-title":"Endoscopic therapy of sclerosing cholangitis","volume":"21","author":"Lee","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib164","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib165","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures","volume":"103","author":"Levy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib166","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib168","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bj\u00f6rnsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib169","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2019.04.001_bib170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib171","doi-asserted-by":"crossref","first-page":"W73","DOI":"10.2214\/AJR.09.3925","article-title":"Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients","volume":"196","author":"Ginat","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.livres.2019.04.001_bib172","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1051-0443(92)72042-9","article-title":"Hemobilia after percutaneous transhepatic biliary drainage: treatment with transcatheter embolotherapy","volume":"3","author":"Savader","year":"1992","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.livres.2019.04.001_bib173","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1148\/radiol.11110254","article-title":"Hepatic arterial injuries in 3110 patients following percutaneous transhepatic biliary drainage","volume":"261","author":"Choi","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.livres.2019.04.001_bib174","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199504000-00011","article-title":"Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis","volume":"20","author":"Jorgensen","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199504000-00011","article-title":"Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis","volume":"20","author":"Jorgensen","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib176","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(81)90491-1","article-title":"Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis","volume":"81","author":"Kaplan","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib177","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.1840140209","article-title":"The metabolic bone disease of primary sclerosing cholangitis","volume":"14","author":"Hay","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib178","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib179","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","article-title":"Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression","volume":"29","author":"Angulo","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib180","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0016-5085(94)90227-5","article-title":"Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis","volume":"107","author":"Ghosh","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib181","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib182","first-page":"1","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"17","year":"2000","journal-title":"NIH Consens Statement"},{"key":"10.1016\/j.livres.2019.04.001_bib183","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib184","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2019.04.001_bib186","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2019.04.001_bib187","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.livres.2019.04.001_bib188","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0016-5085(88)80029-5","article-title":"Fat-soluble vitamin nutriture in primary biliary cirrhosis","volume":"95","author":"Kaplan","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib189","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment","volume":"83","author":"Matloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2019.04.001_bib190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib191","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2019.04.001_bib192","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/j.1572-0241.2002.06031.x","article-title":"Celiac disease in autoimmune cholestatic liver disorders","volume":"97","author":"Volta","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib193","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(78)90480-4","article-title":"Primary biliary cirrhosis and coeliac disease: an association?","volume":"1","author":"Logan","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2019.04.001_bib194","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1590-8658(02)80145-1","article-title":"Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy","volume":"34","author":"Floreani","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/AOG.0000000000001858","article-title":"Clinical updates in women's health care summary: liver disease: reproductive considerations","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.livres.2019.04.001_bib196","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.510260216","article-title":"Intrahepatic cholestasis of pregnancy: a French prospective study","volume":"26","author":"Bacq","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib197","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep.26617","article-title":"Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study","volume":"59","author":"Geenes","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2019.04.001_bib198","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinre.2010.10.007","article-title":"Pathophysiology and current management of pruritus in liver disease","volume":"35","author":"Kremer","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib199","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","article-title":"Liver transplantation in children with progressive familial intrahepatic cholestasis","volume":"84","author":"Englert","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2019.04.001_bib200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bpg.2010.07.010","article-title":"Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy","volume":"24","author":"van der Woerd","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.livres.2019.04.001_bib201","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000450906","article-title":"Role of the intestinal microbiome in cholestatic liver disease","volume":"35","author":"LaRusso","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.livres.2019.04.001_bib202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.livres.2019.04.001_bib203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Comp Physiol"},{"key":"10.1016\/j.livres.2019.04.001_bib204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-014-0048-9","article-title":"MicroRNAs in cholangiopathies","volume":"2","author":"O'Hara","year":"2014","journal-title":"Curr Pathobiol Rep"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568418300394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568418300394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:43:18Z","timestamp":1762872198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568418300394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":204,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2542568418300394"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2019.04.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"type":"print","value":"2542-5684"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Third Affiliated Hospital of Sun Yat-sen University. Publishing Services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}